[go: up one dir, main page]

MA23800A1 - Nouvelle composition - Google Patents

Nouvelle composition

Info

Publication number
MA23800A1
MA23800A1 MA24155A MA24155A MA23800A1 MA 23800 A1 MA23800 A1 MA 23800A1 MA 24155 A MA24155 A MA 24155A MA 24155 A MA24155 A MA 24155A MA 23800 A1 MA23800 A1 MA 23800A1
Authority
MA
Morocco
Prior art keywords
new composition
composition
new
Prior art date
Application number
MA24155A
Other languages
English (en)
Inventor
John Georg Harmenberg
Ann Harrlet Marg Kristofferson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA23800A1 publication Critical patent/MA23800A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
MA24155A 1995-02-06 1996-02-05 Nouvelle composition MA23800A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500114 1995-02-06

Publications (1)

Publication Number Publication Date
MA23800A1 true MA23800A1 (fr) 1996-10-01

Family

ID=20396821

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24155A MA23800A1 (fr) 1995-02-06 1996-02-05 Nouvelle composition

Country Status (30)

Country Link
US (2) USRE39264E1 (fr)
EP (2) EP1419803B1 (fr)
JP (2) JP4260220B2 (fr)
KR (1) KR100431042B1 (fr)
CN (1) CN1131034C (fr)
AR (1) AR002030A1 (fr)
AT (2) ATE421358T1 (fr)
AU (1) AU716809B2 (fr)
CA (1) CA2211389C (fr)
DE (3) DE122010000032I1 (fr)
DK (1) DK0809498T3 (fr)
DZ (1) DZ1966A1 (fr)
ES (1) ES2214528T3 (fr)
FI (1) FI119415B (fr)
FR (1) FR10C0038I2 (fr)
HK (1) HK1004368A1 (fr)
HR (1) HRP960034B1 (fr)
IL (1) IL116913A0 (fr)
MA (1) MA23800A1 (fr)
MY (1) MY119365A (fr)
NO (1) NO314220B1 (fr)
NZ (1) NZ301407A (fr)
PT (1) PT809498E (fr)
SA (1) SA96160590B1 (fr)
SI (1) SI0809498T1 (fr)
TN (1) TNSN96024A1 (fr)
TW (1) TW438585B (fr)
WO (1) WO1996024355A1 (fr)
YU (1) YU49477B (fr)
ZA (1) ZA96527B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
WO2005051931A2 (fr) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase
US7618950B2 (en) * 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
EP1865960A2 (fr) * 2005-03-30 2007-12-19 Novartis AG Penciclovir ou famciclovir destine au traitement de l'herpes genital recidivant avec une application d'un jour
EP1871349A1 (fr) * 2005-04-11 2008-01-02 Nanobio Corporation Halogenures d'ammonium quaternaires pour le traitement de pathologies infectieuses
WO2008051186A2 (fr) * 2005-08-09 2008-05-02 Nanobio Corporation Compositions de nano-émulsion ayant une activité anti-inflammatoire
WO2007031838A1 (fr) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
WO2007045979A1 (fr) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
FR2900577B1 (fr) * 2006-05-04 2008-09-12 Goemar Lab Sa Nouveaux medicaments pour les traitements contre le virus de l'herpes
CA2664247A1 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiesterase type iv
WO2008035316A2 (fr) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibiteurs de phosphodiestérase
EP1958947A1 (fr) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibiteurs de la phosphodiestérase de type 4
DK2124944T3 (da) * 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2124943A1 (fr) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Dérivés de pyrazolo[3,4-b]pyridine comme inhibiteurs de phosphodiestérases
EP2155209A4 (fr) * 2007-04-26 2012-06-13 Univ Pennsylvania Composition d'inhibiteurs d'adn polymérase et procédés de ces inhibiteurs
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
EP2111861A1 (fr) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions d'inhibiteurs de type IV de la phosphodiestérase
US20090291895A1 (en) * 2008-05-23 2009-11-26 Wong Scott W Methods and Compositions for the Treatment of Inflammatory Diseases
WO2011035120A2 (fr) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Composition thérapeutique pour traiter des lésions provoquées par le virus herpès simplex
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
EP2489354A1 (fr) 2011-02-18 2012-08-22 Vironova AB Formulation pharmaceutique de B220 pour le traitement topique de l'herpès
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
WO2014159731A1 (fr) * 2013-03-13 2014-10-02 Nal Pharmaceuticals, Ltd Composition antivirale topique contenant un anesthésique local et son procédé de fabrication
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona
CA3142831A1 (fr) 2019-06-14 2020-12-17 Propella Therapeutics, Inc. Formulations d'acyclovir topique et leurs utilisations
KR102478608B1 (ko) * 2019-06-25 2022-12-19 아주대학교산학협력단 허피스 감염증 마우스 모델의 제조방법
CN112569243A (zh) * 2019-09-30 2021-03-30 神农医药科技有限公司 制备治疗阿尔茨海默病的药物
WO2021231499A2 (fr) * 2020-05-11 2021-11-18 Revir, Inc. Compositions et méthodes de traitement d'infections virales
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en) 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0594224A3 (en) * 1985-09-17 1994-07-13 Wellcome Found Therapeutic nucleosides
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
WO1990006775A1 (fr) * 1988-12-14 1990-06-28 Liposome Technology, Inc. Nouvelle composition de liposomes non phospholipidique a liberation soutenue de medicaments
AU636255B2 (en) * 1990-11-05 1993-04-22 Arthropharm Pty Ltd Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
WO1992019244A2 (fr) * 1991-05-01 1992-11-12 Henry M. Jackson Foundation For The Advancement Of Military Medicine Procede de traitement des maladies respiratoires infectieuses
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
SI0809498T1 (en) 2004-12-31
HK1004368A1 (en) 1998-11-27
IL116913A0 (en) 1996-05-14
JPH11506417A (ja) 1999-06-08
YU7296A (sh) 1998-08-14
EP0809498B1 (fr) 2004-03-31
CA2211389A1 (fr) 1996-08-15
EP0809498A1 (fr) 1997-12-03
PT809498E (pt) 2004-06-30
FR10C0038I2 (fr) 2011-04-29
AU716809B2 (en) 2000-03-09
YU49477B (sh) 2006-05-25
TNSN96024A1 (fr) 2005-03-15
ATE421358T1 (de) 2009-02-15
KR19980701959A (ko) 1998-06-25
NZ301407A (en) 1999-01-28
JP4260220B2 (ja) 2009-04-30
FI973243A0 (fi) 1997-08-06
EP1419803A2 (fr) 2004-05-19
AR002030A1 (es) 1998-01-07
CN1179718A (zh) 1998-04-22
DE69632034D1 (de) 2004-05-06
DE69632034T2 (de) 2004-10-14
FR10C0038I1 (fr) 2010-10-15
DZ1966A1 (fr) 2002-10-15
ZA96527B (en) 1996-08-06
TW438585B (en) 2001-06-07
EP1419803A3 (fr) 2004-06-09
DK0809498T3 (da) 2004-05-10
DE69637828D1 (de) 2009-03-12
SA96160590B1 (ar) 2005-10-05
AU4682196A (en) 1996-08-27
JP2007284452A (ja) 2007-11-01
USRE39264E1 (en) 2006-09-05
CN1131034C (zh) 2003-12-17
MY119365A (en) 2005-05-31
HRP960034A2 (en) 1997-10-31
NO314220B1 (no) 2003-02-17
ATE262907T1 (de) 2004-04-15
WO1996024355A1 (fr) 1996-08-15
US6337324B1 (en) 2002-01-08
FI119415B (fi) 2008-11-14
ES2214528T3 (es) 2004-09-16
NO973612L (no) 1997-09-26
DE122010000032I1 (de) 2010-10-21
EP1419803B1 (fr) 2009-01-21
FI973243A (fi) 1997-08-06
CA2211389C (fr) 2007-11-20
KR100431042B1 (ko) 2004-06-16
NO973612D0 (no) 1997-08-05
HRP960034B1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
MA23800A1 (fr) Nouvelle composition
FI974241A0 (fi) BPM-15 -koostumukset
UY24316A1 (es) Composiciones refrescantes
DE69635258D1 (de) Schmiermittelzusammensetzung
DE19681044T1 (de) Schmiermittel-Zusammensetzung
BR9607635A (pt) Composição detergente
KR970002471A (ko) 포지티브형 포토레지스트조성물
DE69607710D1 (de) Lichtempfindliche Zusammensetzung
BR9608126A (pt) Composição detergente
ATE179963T1 (de) Bronzefarbene glaszusammensetzung
DE69618514D1 (de) Waschmittelzusammensetzung
BR9607058A (pt) Composição
BR9606809A (pt) Composição inseticidamente ativa
NO981568D0 (no) Randtennings-tennsatssammensetninger
DE69605381D1 (de) Fotoresistzusammensetzung
DE69617029D1 (de) Organoton-zusammensetzungen
PT728814E (pt) Composicao betuminosa
DE69616104D1 (de) Lichtempfindliche Zusammensetzung
BR9609903A (pt) ComposiçÃo inseticidamente ativa
DE69626767D1 (de) Waschmittelzusammensetzung
DE69616374D1 (de) Germizide zusammensetzung
MA23799A1 (fr) Nouvelle composition
DE69603228D1 (de) Aluminoxanate-Zusammensetzungen
ATE206150T1 (de) Farbstoffstabilisierte zusammensetzungen
DE69603749D1 (de) Feste zusammensetzung